These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 2214165

  • 1. [Anti-coagulant therapy--antithrombin III].
    Tsuji H.
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [Abstract] [Full Text] [Related]

  • 2. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W.
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [Abstract] [Full Text] [Related]

  • 3. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S, Tomita H, Yoshida M, Hori T, Igarashi C, Fujita S.
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [Abstract] [Full Text] [Related]

  • 4. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J, Swietliński J, Podleśny-Owsińska T.
    Pol Tyg Lek; 1996 Sep; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract] [Full Text] [Related]

  • 5. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G, Reiter B, Hellstern P, Wenzel E, Köhler M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Sep; 111(4):426-38. PubMed ID: 6083907
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U, Groll A, Kreuz WD, Brand M, Breddin HK, von Loewenich V, Kornhuber B.
    Klin Padiatr; 1992 Sep; 204(3):134-40. PubMed ID: 1614177
    [Abstract] [Full Text] [Related]

  • 7. [Use of antithrombin III concentrates].
    Vinazzer H.
    Beitr Infusionsther; 1989 Sep; 24():151-8. PubMed ID: 2481532
    [Abstract] [Full Text] [Related]

  • 8. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T, Abe T, Takita H.
    Am J Pediatr Hematol Oncol; 1985 Sep; 7(1):3-8. PubMed ID: 4037242
    [Abstract] [Full Text] [Related]

  • 9. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M, Fukuoka N, Nishiyama T, Maekawa S, Shirakawa Y.
    Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
    [Abstract] [Full Text] [Related]

  • 10. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C, Páramo JA, Rocha E.
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW.
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [Abstract] [Full Text] [Related]

  • 13. Substitution of antithrombin III.
    Breddin HK, Kirchmaier CM.
    Wien Klin Wochenschr; 1984 Dec 21; 96(24):875-9. PubMed ID: 6528616
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
    von Kries R, Stannigel H, Göbel U.
    Eur J Pediatr; 1985 Jul 21; 144(2):191-4. PubMed ID: 4043133
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Consumption coagulopathies following peritoneojugular bypass. Prevention by a heparin-antithrombin III combination].
    Peyrin JC, Waldmann V, Girardet P, Pouzol P, Duret J, Fargnoli JM, Magne JL, Perron Y.
    J Chir (Paris); 1986 Jul 21; 123(6-7):417-23. PubMed ID: 3771670
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
    Gotoh K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr 21; 37(4):571-80. PubMed ID: 3989338
    [Abstract] [Full Text] [Related]

  • 19. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I.
    Hokkaido Igaku Zasshi; 1987 Jan 21; 62(1):108-21. PubMed ID: 3817736
    [Abstract] [Full Text] [Related]

  • 20. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R.
    Semin Hematol; 1995 Oct 21; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.